Vancouver, British Columbia – TheNewswire - October 3, 2022. Lexston Life Sciences Corp. (CSE:LEXT), (OTC:LEXTF) (“Lexston”) granted 3,000,000 stock options to its directors, officers, consultants, and employees.  

Each stock option is exercisable at $0.05 per share.  The options vest immediately and expire on October 3, 2027.

All options were granted pursuant to the 10% rolling stock option plan of Lexston dated January 15, 2021 (the “Plan”).  

As of the date of this news release Lexston has 3,000,000 stock options granted and 30,917 stock options available for future grants.

About Lexston Life Sciences Corp.

Lexston Life Sciences Corp. has been active in establishing strategic relationships towards executing the goal of acquiring assets and businesses.  Lexston has purchased two companies that provide cannabis testing and research services.

On Behalf of the Board of Directors

LEXSTON LIFE SCIENCES CORP.

Jagdip Bal Chief Executive Officer

Telephone: (604) 928-8913

Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.